Modeling gene regulatory mechanisms contributing to the evolution of the human cerebral cortex
Project Number5F32HD108935-03
Contact PI/Project LeaderBAUMGARTNER, MARY
Awardee OrganizationYALE UNIVERSITY
Description
Abstract Text
Project Summary
The vast expansion of the human cerebral cortex distinguishes us from our primate relatives, and this cortical
expansion is the foundation of uniquely human higher-order cognition. Numerous developmental innovations,
such as increased proliferation of cortical progenitor cells, contributed to this cortical growth. Ultimately, these
developmental innovations arose from genetic changes in the human lineage, which altered the molecular and
cellular programs underpinning development. Understanding the gene regulatory networks that specifically
inform human cortical development and cortical size is crucial for understanding the etiology of
neurodevelopmental disorders, which often present with cognitive impairment. Efforts to identify human-specific
genetic changes have revealed Human Accelerated Regions (HARs), which are highly conserved regulatory
elements that exhibit a high rate of human-specific sequence change. A growing body of evidence implicates
HARs in cortical development and evolution. In particular, the HAR HACNS205 has (i) human-biased
accessibility in cerebral organoids, compared to chimpanzee, and evidence of enhancer activity; (ii) an essential
role in human neural stem cell proliferation; and (iii) a known target gene in the fetal human cortex, BRN2, a
transcription factor that regulates corticogenesis and has human-biased expression in cortical progenitor cells
relative to chimp. BRN2 is an autism risk gene, and its target genes display enrichment for autism risk genes.
In addition, clinical work has linked BRN2 mutations to global developmental delay and cognitive impairment.
BRN2 has also recently been implicated in human cortical evolution. Overexpression studies indicate BRN2 is
important for designating neural progenitor cell identity, the timing of neurogenesis, and the production of specific
neuronal subtypes. However, the role of HACNS205 in human cortical development is not clear; moreover, the
role of BRN2 in early cortical development has not been reported. The goal of this proposal is to address these
gaps in the field, by using a humanized mouse model to study how HACNS205 impacts BRN2 expression levels
and BRN2 transcription factor binding, and how these primary molecular effects shape gene expression,
molecular networks, progenitor cell behavior, and the timing of key events in cortical development. Specifically,
I will employ genome-wide epigenetic and single-cell transcriptomic analyses of embryonic cortical development.
These results will then be leveraged to perform targeted phenotypic analysis of the developing cortex in these
mice, to identify HACNS205-driven shifts in progenitor cell behavior, neurogenesis, and ultimately cortical
morphology. The applicant’s long-term goal is to study the emergence of novel cell types in brain evolution. This
fellowship will aid the applicant in developing the expertise in bioinformatics and evolutionary, regulatory, and
functional genomics that will greatly bolster her success in this line of research, complementing her current
expertise in neurobiology and cortical development.
Public Health Relevance Statement
Project Narrative
The human cerebral cortex is greatly expanded compared to other primates, which is ultimately caused by
genetic changes that affect gene expression regulation and how the human cerebral cortex develops. My goal
is to reveal how a specific region of human-specific genetic change and human innovations in gene regulation
shape cortical development and evolution, by using novel mouse models. This knowledge of how uniquely
human genetic and developmental change affect growth of the cerebral cortex, an important structure for
higher-order cognition, is crucial for understanding the etiology of disorders affecting humans, such as
neurodevelopmental disorders and cognitive impairment.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
865
DUNS Number
043207562
UEI
FL6GV84CKN57
Project Start Date
01-September-2022
Project End Date
31-August-2025
Budget Start Date
01-September-2024
Budget End Date
31-August-2025
Project Funding Information for 2024
Total Funding
$81,364
Direct Costs
$81,364
Indirect Costs
Year
Funding IC
FY Total Cost by IC
2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$81,364
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5F32HD108935-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5F32HD108935-03
Patents
No Patents information available for 5F32HD108935-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5F32HD108935-03
Clinical Studies
No Clinical Studies information available for 5F32HD108935-03
News and More
Related News Releases
No news release information available for 5F32HD108935-03
History
No Historical information available for 5F32HD108935-03
Similar Projects
No Similar Projects information available for 5F32HD108935-03